Skip to main content
Equibles
BWAY logo

BWAY · Brainsway Ltd.

Track BWAY — free

Use BWAY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about BWAY

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$16.32 -0.15 (-0.91%) At close · Aug 14
Market Cap
$654.94M
Shares
40.13M

Brainsway Ltd. Earnings Call Transcripts

Every quarterly earnings call for Brainsway Ltd. (BWAY) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Conference
Investor event
2026-10-17
7TH EUROPEAN CONFERENCE ON BRAIN STIMULATION IN MENTAL HEALTH
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-26
WORLD PSYCHIATRY AND MENTAL HEALTH CONFERENCE 2026
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-25
4th Conference on Advances in Neuromodulation
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-11
Brainsway Ltd. Q1 FY2026 Earnings Call
Confident tone Neurolief / ProlivRx partnership Clinical pipeline and FDA submissions Recurring revenue model and RPO
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-11
Brainsway Ltd. Q3 FY2025 Earnings Call
Confident tone Accelerated FDA protocol and clinical pipeline Deep TMS system shipments and installed base Revenue growth and guidance raise
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Brainsway Ltd. Q2 FY2025 Earnings Call
Confident tone Clinical evidence and regulatory indications Next-gen TMS 360 platform and new indications Recurring revenue and multiyear lease model
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Brainsway Ltd. Q1 FY2025 Earnings Call
Confident tone Revenue Growth & Shipments Accelerated MDD Protocol / R&D OCD Indication
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Brainsway Ltd. Q4 FY2024 Earnings Call
Confident tone Profitability and Cash Generation Revenue Growth and Shipments Depression/Anxious Depression/Elderly MDD
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Brainsway Ltd. Q3 FY2024 Earnings Call
Confident tone Revenue growth and guidance Deep TMS system and next-generation platform International expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Brainsway Ltd. Q2 FY2024 Earnings Call
Confident tone International expansion FDA label expansion for MDD in elderly Revenue growth and guidance
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Brainsway Ltd. Q1 FY2024 Earnings Call
Confident tone Revenue Growth and Financial Performance Clinical Evidence and R&D Pipeline Deep TMS Installed Base and System Shipments
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Brainsway Ltd. Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–12 of 12 earnings calls
Key facts CIK 1505065 CUSIP 10501L106 13F (30d) 54 filings 53 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)